Journal of Antimicrobial Chemotherapy (2002) 49, 353-357
© 2002 The British Society for Antimicrobial Chemotherapy
Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis
a Department of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 7881, San Antonio, TX 78229-3900; b Audie Murphy Division, South Texas Veterans Health Care System, San Antonio, TX 78284, USA
Ravuconazole (BMS-207147, ER-30346), an oral triazole, was evaluated in an immunosuppressed temporarily neutropenic guinea pig model of invasive aspergillosis. In this model, guinea pigs were immunosuppressed with triamcinolone 20 mg/kg sc od beginning 4 days before challenge and made neutropenic with cyclophosphamide 300 mg/kg ip 1 day before challenge. Treatments of ravuconazole 5, 10 and 25 mg/kg po od were compared with itraconazole 2.5 and 5.0 mg/kg po bd and amphotericin B 1.25 mg/kg ip od. Treatment began 24 h after lethal intravenous challenge with Aspergillus fumigatus and continued for 5 days. Mortality occurred in eight of eight untreated control animals versus none of eight treated with ravuconazole 5 or 10 mg/kg/day or itraconazole 10 mg/kg/day. Mortality occurred in one of eight animals treated with ravuconazole 25 mg/kg/day, one of eight with amphotericin B and two of eight treated with itraconazole 5 mg/kg/day. Compared with controls, each of the antifungals examined significantly reduced the tissue burden in liver and brain, although only the highest doses of the azole drugs and amphotericin B significantly reduced tissue burden in the kidney. All three doses of ravuconazole improved survival and also reduced the tissue burden of Aspergillus. In this model of invasive aspergillosis, ravuconazole showed significant activity and may be a useful compound in human disease.
* Corresponding author. Tel: +1-210-567-4823; Fax: +1-210-567-3303; E-mail: kirkpatrick{at}uthscsa.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. C. Pasqualotto and D. W. Denning New and emerging treatments for fungal infections J. Antimicrob. Chemother., January 1, 2008; 61(suppl_1): i19 - i30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Kirkpatrick, B. J. Coco, and T. F. Patterson Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1567 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Groll, D. Mickiene, V. Petraitis, R. Petraitiene, A. Kelaher, A. Sarafandi, G. Wuerthwein, J. Bacher, and T. J. Walsh Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits J. Antimicrob. Chemother., November 1, 2005; 56(5): 899 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cuenca-Estrella, A. Gomez-Lopez, E. Mellado, G. Garcia-Effron, and J. L. Rodriguez-Tudela In Vitro Activities of Ravuconazole and Four Other Antifungal Agents against Fluconazole-Resistant or -Susceptible Clinical Yeast Isolates Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3107 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Pfaller, D. J. Sheehan, and J. H. Rex Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization Clin. Microbiol. Rev., April 1, 2004; 17(2): 268 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Petraitiene, V. Petraitis, C. A. Lyman, A. H. Groll, D. Mickiene, J. Peter, J. Bacher, K. Roussillon, M. Hemmings, D. Armstrong, et al. Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1188 - 1196. [Abstract] [Full Text] [PDF]
|
|